COVID-19 in Patients with Rheumatic Disease Using Immunomodulatory Drugs: Imaging Findings and Predictors of Hospitalization.

Hossein AziziHanie KarimiMahdi KazemiSomaye Sadat RezaeiAmirhossein ParsaeiMohammad AghaaliJamshid VafaeimaneshPouya TorabiBehnam AminiMaryam Masoumi

Published in: Rheumatology and therapy (2022)

This study found that advanced age and comorbidities, similar to the general population, are risk factors for hospitalization in patients with COVID-19 with rheumatic disorders. Administration of csDMARDs, older age, and pulmonary disorders were linked to increased risk of COVID-19 pneumonia in these individuals.

Keyphrases

coronavirus disease
sars cov
rheumatoid arthritis
high resolution
pulmonary hypertension
physical activity
respiratory syndrome coronavirus
community dwelling
middle aged
mass spectrometry
drug induced
acute respiratory distress syndrome
respiratory failure